← Mechanisms of action
LAG3
SINGLE PROTEINHomo sapiens
Preferred name: Lymphocyte activation gene 3 protein ChEMBL ↗
Linked proteins
Drugs acting on this target (19)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| bi 754111 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| bms-986016 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| eftilagimod alpha | Inhibitor | experimental | Recombinant protein | LAG3 inhibitor |
| emb-02 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| fs118 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| gsk2831781 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| ibi110 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| incagn02385 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| lag525 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| mgd013 | Inhibitor | experimental | mAb | Lymphocyte activation gene 3 protein inhibitor |
| mk-4280 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| regn3767 | Inhibitor | experimental | mAb | Lymphocyte activation gene 3 protein inhibitor |
| relatlimab (Opdualag) | Inhibitor | approved | mAb | Lymphocyte activation gene 3 protein inhibitor |
| ro7247669 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| ssgj-709 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| sym022 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| tsr-033 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| xmab22841 | Inhibitor | experimental | mAb | LAG3 inhibitor |
| eftilagimod alpha | Vaccine antigen | experimental | Recombinant protein | Lymphocyte activation gene 3 protein vaccine antigen |